Zimmer Biomet Holdings Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Zimmer Biomet Holdings Inc 's ROA in the third quarter of 2026?
Zimmer Biomet Holdings Inc achieved a return on average assets (ROA) of 3.06 % in its third quarter of 2026, which is below Zimmer Biomet Holdings Inc 's average return on assets, which stands at 3.6%.

ROA decreased relative to the period ending Jun 30 2026, due to the decline in net income.

However, within the Healthcare sector 175 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 1524, from total ROA ranking in the second quarter of 2026 at 1854.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	17.94 %	17.63 %	2.42 %	8.08 %	8.14 %
Y / Y Net Income Change	-17.13 %	30.12 %	30.5 %	-42.52 %	-7.26 %
Net Income (TTM) in million	768	807	761	705	807
Return On Assets (TTM)	3.06 %	3.36 %	3.3 %	3.08 %	3.59 %
ZBH's Total Ranking	# 1524	# 1854	# 1472	# 1418	# 1333
Total Assets (TTM) in million	27,702	26,897	22,722	23,092	23,488
Seq. Total Assets Change	2.99 %	18.38 %	-1.6 %	-1.69 %	2.72 %
Seq. Net Income Change	-4.01 %	-16.24 %	72.68 %	-40.31 %	50.72 %

ZBH's 5 Years Annual ROA >> Back to ZBH Management Effectiveness >> Compare ZBH ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 53
Sector	# 176
Overall	# 1477

Return On Assets Statistics
High	Average	Low
9.29 %	3.6 %	-1.48 %
(Sep 30 2010)		(Dec 31 2018)

Financial Statements
Zimmer Biomet Holdings Inc 's Assets	$ 27,702 million	ZBH's Balance sheet
Zimmer Biomet Holdings Inc 's Income	$ 192 million	Quarterly ZBH's Income Statement
ZBH's Income by Division		See ZBH's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	8.08 %	-0.61 %	2.05 %	-10.19 %	-3.94 %
Total Assets in million	23,092	21,365	21,497	21,066	23,456
Y / Y Net Income Change	-22.1 %	-11.69 %	341.09 %	-42.2 %	-
Net Income in million	705	905	1,025	232	402
Annual Return On Assets	3.05 %	4.24 %	4.77 %	1.1 %	1.71 %

ZBH's 5 Years Annual ROA >> Back to ZBH Management Effectiveness >> Compare ZBH ROA to its Competitors

Comment on ZBH's ROA in the fiscal year ending 2025

In the fiscal year 2025 Zimmer Biomet Holdings Inc 's ROA decreased compared to previous year to 3.05 %, due to deterioration of net income -22.1 % to $705.20 million, from $905.30 million a year ago, as ZBH's assets were $23,091.70 million.

More Return On Assets Ratios
ZBH's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ZBH's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ZBH's Competitors
Subscribers only: Roa for Zimmer Biomet Holdings Inc 's Suppliers
Subscribers only: Return On Assets for ZBH's Customers

You may also want to know
ZBH's Roi	ZBH's Inventory Turnover Ratio	ZBH's Growth Rates	ZBH's Dividend Comparisons
	ZBH's Profitability Ratios	ZBH's Asset Turnover Ratio	ZBH's Dividend Growth
ZBH's Roe	ZBH's Valuation Ratios	ZBH's Financial Strength Ratios	ZBH's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Penumbra Inc	8.13 %
Johnson and Johnson	8.06 %
Pacific Health Care Organization Inc	7.83 %
Boston Scientific Corporation	7.82 %
Ani Pharmaceuticals Inc	7.77 %
Stryker Corp	7.66 %
Abbvie Inc	7.48 %
Ensign Group Inc	7.00 %
Pediatrix Medical Group Inc	6.99 %
Quest Diagnostics Inc	6.96 %
Davita Inc	6.65 %
Brightspring Health Services Inc	6.60 %
Ge Healthcare Technologies Inc	5.85 %
Merit Medical Systems Inc	5.72 %
Incyte Corporation	5.48 %
Labcorp Holdings Inc	5.36 %
Sotera Health Company	5.26 %
Black Hawk Acquisition Corporation	5.19 %
Pacs Group Inc	4.87 %
Iqvia Holdings Inc	4.65 %
Teleflex Incorporated	4.54 %
Haemonetics Corporation	4.30 %
Henry Schein Inc	3.84 %
U S Physical Therapy Inc	3.47 %
Lifestance Health Group Inc	3.30 %
Conmed Corporation	3.18 %
Integer Holdings Corporation	3.04 %
Avantor Inc	2.89 %
Ligand Pharmaceuticals Incorporated	2.74 %
Innovage Holding Corp	2.04 %

Date modified: 2026-11-07T13:17:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.